Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
-2.58M
-
Total reported value, excl. options
-
$17.1M
-
Value change
-
-$3.74M
-
Put/Call ratio
-
0.2
-
Number of buys
-
33
-
Number of sells
-
-43
-
Price
-
$1.24
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2024
99 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q2 2024.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 43.4M outstanding shares and own 31.81% of the company stock.
Largest 10 shareholders include Bleichroeder LP (2.86M shares), Slate Path Capital LP (2.4M shares), VANGUARD GROUP INC (2.03M shares), BlackRock Inc. (757K shares), MILLENNIUM MANAGEMENT LLC (494K shares), GEODE CAPITAL MANAGEMENT, LLC (492K shares), Robertson Stephens Wealth Management, LLC (479K shares), NORTHERN TRUST CORP (350K shares), Good Life Advisors, LLC (325K shares), and GSA CAPITAL PARTNERS LLP (278K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.